Angioid Streaks - 9 Studies Found

Withdrawn : Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks
: Angioid Streaks
: 2009-11-17
: Drug: ranibizumab 0.5 mg dose of ranibizumab. Treatment will be given at baseline, month 1, and month 2,
Withdrawn : Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID).
: Choroidal Neovascularization in Angioid Streaks
: 2015-10-07
: Drug: Aflibercept The patients are followed on a monthly basis until 52 weeks. Intravitreal injections o
Withdrawn : Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
:
  • Angioid Streaks
  • Choroidal Neovascularization

: 2006-06-30
: Drug: Intravitreal Bevacizumab
Completed : Intravitreal Bevacizumab in Agioid Streaks
:
  • Angioid Streaks
  • Choroidal Neovascularization

: 2006-11-30
:
  • Drug: intravitreal injection 1
Withdrawn : Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
:
  • Choroidal Neovascularization
  • Myopia
  • Punctate Inner Choroid
    : 2010-10-29
    :
    • Drug: Bevacizumab (Avastin; Genentech, Inc.)

Completed : Evolution of Visual Impairment During Pseudoxanthoma Elasticum
: Pseudoxanthoma Elasticum
: 2007-11-06
Recruiting : Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)
: Pseudoxanthoma Elasticum
: 2015-08-21
: Drug: Aflibercept Intravitreal injection Other Name:
Completed : Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)
: Choroidal Neovascularization
: 2007-08-01
: Drug: Intravitreal injection ranibizumab Monthly intravitreal injection of 0.5mg ranibizumab in one eye
Completed : Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
: Choroidal Neovascularization
: 2006-08-30
: Drug: bevacizumab